Signal Explorer
Monday, June 1 · 10-K · 10-Q · 8-K · search any ticker above
30
Filings
30
Companies
0
Signals Fired
Nyse Listing Disclosure
Top Signal
Trending Classifiers
Other
Auditor Appointment Ratification
Auditor Change
Form 8K Filing Disclosure
Core
Clinical Trial Result
Indication Expansion
Lead Asset Progress
Secondary Endpoint Mentioned
Combination Therapy Mentioned
Other
Publication Positive
Patient Retention High
Priority Review Or Pdufa Disclosed
Safety Differentiated
Kol Endorsement
Fast Track Designation Received
Fast Track Granted
Fda Aligned
Ceo Team Pride Statement
Biotech Risk
Trial Endpoint Missed
Core
Management Exodus
Other
Executive Educational Background Disclosure
Executive Transition Gratitude Statement
Geographic Footprint Disclosure
Classified Board Director Election
Board Diversity Policy Disclosed
Rsu Psu Vesting Schedule Disclosed
Core
Management Exodus
Other
Executive Educational Background Disclosure
Forward Looking Statement Definition
Executive Transition Gratitude Statement
Director Continuity Stated
Rsu Psu Vesting Schedule Disclosed
Board Diversity Policy Disclosed
Employee Director Compensation Waiver
Other
Amendment Modification Waiver Clause
Corporate Authority Representation
Corporate Organization And Standing Representation
Non Assignment Clause
No Regulatory Approval Required
Survival Of Representations Warranties Clause
Restricted Stock Certificate Legend Required
Other
Nyse Listing Disclosure
Merger Proxy Statement Disclosure
Form S3 Shelf Registration Disclosure
Other
Auditor Appointment Ratification
Classified Board Director Election
Say On Pay Vote Result Disclosed
Other
Fcpa Compliance Representation
Prime Rate Determination Methodology
Other
Nasdaq Minimum Bid Price Delisting Notice
Form 8K Filing Disclosure
Other
Insider Buying
Registrant Bears Registration Expenses
Corporate Authority Representation
New York Jurisdiction Clause
Amendment Modification Waiver Clause
Fcpa Compliance Representation
Tax Advisor Consultation Urged
Corporate Organization And Standing Representation
Survival Of Representations Warranties Clause
Forward Looking Statement Definition
Registration Rights Piggyback Provision
Non Assignment Clause
Indemnification Consent Requirement
Merger Proxy Statement Disclosure
No Regulatory Approval Required
Other
Quarterly Dividend Declared
Bitcoin Technology Description
Other
Change Of Control Definition
Restrictive Debt Covenants Disclosure
Debt Note Interest Terms Disclosed
Debt Note Maturity Date Disclosure
Ipo Net Proceeds Disclosure
Successor Agent Appointment Provision
Change Of Control Redemption Provision
Ipo Or Capital Raising Completion
Use Of Proceeds Disclosure
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Clinical Hold
Other
Patient Retention High
Kol Endorsement
Publication Positive
Safety Differentiated
Fast Track Designation Received
Enrollment Ahead Of Schedule
Orphan Status Granted
Breakthrough Therapy Granted
Biotech Risk
Trial Endpoint Missed
Accelerated Approval
Clinical Hold Active
Other
Executive Educational Background Disclosure
Executive Severance Change Of Control
Severance Payment Obligation
Employment Termination Upon Death
Confidential Information Return Obligation
Executive Expense Reimbursement Provision
Cause For Termination Defined
President Duties Defined
Non Assignment Clause
Covid19 Pandemic Uncertainty Disclosure
Non Solicitation Covenant
Employee Director Compensation Waiver
Section 409A Compliance Statement
Other
Nyse Listing Disclosure
Classified Board Director Election
Director Officer Indemnification Provision
New York Jurisdiction Clause
Advance Notice Requirement Disclosed
Adjournment Proposal Voting Requirement
Amendment Modification Waiver Clause
Indemnification Consent Requirement
Multi Class Voting Structure Disclosed
Record Date Procedures Disclosed
Committee Meeting Attendance Disclosure
Stock Certificate Signature Requirement
Quorum Adjournment Provision
Corporate Organization And Standing Representation
Change Of Control Definition
Other
Ipo Net Proceeds Disclosure
Sanctions Compliance Representation
Nyse Listing Disclosure
Fcpa Compliance Representation
Investment Company Act Exemption Claimed
Use Of Proceeds Disclosure
Registration Rights Piggyback Provision
Coinvestment Exemptive Order Requested
Corporate Organization And Standing Representation
Ipo Or Capital Raising Completion
Other
Use Of Proceeds Disclosure
Other
Institutional Investment
Use Of Proceeds Disclosure
Ipo Net Proceeds Disclosure
Ipo Or Capital Raising Completion
Other
Share Repurchase Activity Disclosed
Biotech Risk
Trial Endpoint Missed
Other
Patient Retention High
Publication Positive
Interim Data Positive
Core
Clinical Trial Result
Lead Asset Progress
Clinical Hold
Secondary Endpoint Mentioned
Core
Management Exodus
Other
Confidential Information Return Obligation
Executive Severance Change Of Control
Confidential Information Definition
Severance Payment Obligation
Adea Waiver Release
Non Solicitation Covenant
New York Jurisdiction Clause
Section 409A Compliance Statement
Diversity Equity Inclusion Commitment
Successor Agent Appointment Provision
Other
Board Diversity Policy Disclosed
Director Continuity Stated
Audit Committee Independence Certification
Other
Forward Looking Statement Definition
Other
Quorum Presence Disclosed
Multi Class Voting Structure Disclosed
Record Date Disclosure
Other
Adjusted Ebitda Period Comparison
Free Cash Flow Metric Disclosed
Form 8K Filing Disclosure
Pro Forma Disclaimer
Use Of Proceeds Disclosure
Transfer And Demand Rights Limitations
Core
Indication Expansion
Other
Credit Agreement Schedule Amendment
Other
Form S3 Shelf Registration Disclosure
Merger Proxy Statement Disclosure
Core
Management Exodus
Other
Executive Transition Gratitude Statement
Board Diversity Policy Disclosed
Other
Basel Iii Capital Ratio Requirements Disclosed
Interest Income Year Over Year Comparison
Other
Quarterly Loan Deposit Growth Comparison